Literature DB >> 6668558

Nonlinear assessment of nitrofurantoin bioavailability in rabbits.

N Watari, T Funaki, K Aizawa, N Kaneniwa.   

Abstract

The influence of route of administration on the absolute bioavailability and GI tract absorption of nitrofurantoin was investigated in rabbits. The disposition of nitrofurantoin was described by a one-compartment model with simultaneous first-order and Michaelis-Menten type elimination kinetics, and bioavailability was estimated by nonlinear assessment. The plasma levels following oral administration were significantly lower than those after intravenous administration, and absolute F values for oral administration were approximately 0.3. However, F values following intraduodenal administration and portal vein infusion were nearly unity, and it was concluded that the reduction of bioavailability following oral administration could not be attributed to metabolism by intestinal microflora or to the hepatic first-pass effect. Thus, reduction of F values following oral administration is probably due to gastric degradation of the drug. The effects of factors influencing bioavailability, such as water volume taken with the drug, change of gastric emptying rate and effect of particle size, were also investigated. Increase of volume of water administered tended to improve the bioavailability, and a particle size dependency was also observed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6668558     DOI: 10.1007/bf01062210

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  28 in total

1.  Renal tubular transport of nitrofurantoin.

Authors:  J A BUZARD; R C BENDER; E G NOHLE; D T HUMPHREY; M F PAUL
Journal:  Am J Physiol       Date:  1962-06

2.  Bioavailability studies of acetaminophen and nitrofurantoin.

Authors:  K S Albert; A J Sedman; P Wilkinson; R G Stoll; W J Murray; J G Wagner
Journal:  J Clin Pharmacol       Date:  1974 May-Jun       Impact factor: 3.126

3.  Inconsistencies in rationale underlying official USP dissolution rate specifications for nitrofurantoin.

Authors:  T R Bates; H A Rosenberg; A V Tembo
Journal:  J Pharm Sci       Date:  1973-12       Impact factor: 3.534

4.  Urinary drug excretion in dogs during therapeutic doses of different nitrofurantoin dosage forms.

Authors:  J D Conklin; R J Sobers; D L Wagner
Journal:  J Pharm Sci       Date:  1969-11       Impact factor: 3.534

5.  Urinary drug excretion in man during oral dosage of different nitrofurantoin formulations.

Authors:  J D Conklin; F J Hailey
Journal:  Clin Pharmacol Ther       Date:  1969 Jul-Aug       Impact factor: 6.875

6.  Fluorescence assay of nitrofurantoin with o-aminothiophenol in plasma and urine.

Authors:  N Watari; T Funaki; N Kaneniwa
Journal:  J Pharm Sci       Date:  1980-01       Impact factor: 3.534

7.  Laboratory studies with nitrofurantoin. Relationship between crystal size, urinary excretion in the rat and man, and emesis in dogs.

Authors:  H E Paul; K J Hayes; M F Paul; A R Borgmann
Journal:  J Pharm Sci       Date:  1967-07       Impact factor: 3.534

8.  Evaluation of oral dilution as a first aid measure in poisoning.

Authors:  M L Henderson; A L Picchioni; L Chin
Journal:  J Pharm Sci       Date:  1966-11       Impact factor: 3.534

9.  Excretion of nitrofurantoin in dog hepatic bile.

Authors:  J D Conklin; D L Wagner
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

10.  Renal excretion of nitrofurantoin (furadantin).

Authors:  M F PAUL; R C BENDER; E G NOHLE
Journal:  Am J Physiol       Date:  1959-09
View more
  2 in total

1.  Effect of pregnancy on nitrofurantoin disposition in mice.

Authors:  Yi Zhang; Lin Zhou; Jashvant D Unadkat; Qingcheng Mao
Journal:  J Pharm Sci       Date:  2009-11       Impact factor: 3.784

2.  Co-Crystal Formation of Antibiotic Nitrofurantoin Drug and Melamine Co-Former Based on a Vibrational Spectroscopic Study.

Authors:  Ziming Zhang; Qiang Cai; Jiadan Xue; Jianyuan Qin; Jianjun Liu; Yong Du
Journal:  Pharmaceutics       Date:  2019-01-30       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.